rabbit antiserum elicited against calf thymus dna modified to 4.4 % ( pt drug/nucleotide ratio = 0.044 ) with the antitumor drug cis-diamminedichloroplatinum ( ii ) ( cis-ddp ) contains antibodies specific for the pt-modified dna immunogen as well as for pt-dna adducts formed in both cultured mouse leukemia l1210 cells and in l1210 cells from the ascites fluid of tumor-bearing mice exposed to cis-ddp .
C0012854
dna
C0242958
dna adducts